Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Ziai

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Advanced Genetics (Hoboken, N.J.)|January 9, 2023
Embryonic lethality and defective mammary gland development of activator-function impaired conditional knock-in <i>Erbb3</i> <sup></sup> miceKate Senger, Wenlin Yuan, Meredith Sagolla, et al.
Gigascience|August 29, 2025
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysisXiao Li, Ximo Pechuan-Jorge, Tyler Risom, et al.
Nature Communications|August 31, 2016
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinomaJeffrey J Wallin, Johanna C Bendell, Roel Funke, et al.
Cancer Immunology Research|February 25, 2026
VSIG4 restricts hepatocellular carcinoma control by suppressing tumor-specific CD8+ T cell immunity in the tumor microenvironmentJinglong Guo, Siddheshvar Bhela, Monica Sharma, et al.
Molecular Cancer Therapeutics|February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian CancerAmy A Lo, Jennifer Johnston, Ji Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibilityJennifer L Shepard, James F Amatruda, Howard M Stern, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapyAnnie Ogasawara, James R Kiefer, Herman Gill, et al.
Nature Communications|September 23, 2023
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancerLucia Taraborrelli, Yasin Şenbabaoğlu, Lifen Wang, et al.
Nature Immunology|March 22, 2022
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunityRosa Barreira da Silva, Ricardo M Leitao, Ximo Pechuan-Jorge, et al.
Nature Communications|August 5, 2023
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumorsAlessandra Castiglioni, Yagai Yang, Katherine Williams, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Advanced Genetics (Hoboken, N.J.)|January 9, 2023
Embryonic lethality and defective mammary gland development of activator-function impaired conditional knock-in <i>Erbb3</i> <sup></sup> miceKate Senger, Wenlin Yuan, Meredith Sagolla, et al.
Gigascience|August 29, 2025
SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysisXiao Li, Ximo Pechuan-Jorge, Tyler Risom, et al.
Nature Communications|August 31, 2016
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinomaJeffrey J Wallin, Johanna C Bendell, Roel Funke, et al.
Cancer Immunology Research|February 25, 2026
VSIG4 restricts hepatocellular carcinoma control by suppressing tumor-specific CD8+ T cell immunity in the tumor microenvironmentJinglong Guo, Siddheshvar Bhela, Monica Sharma, et al.
Molecular Cancer Therapeutics|February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian CancerAmy A Lo, Jennifer Johnston, Ji Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2005
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibilityJennifer L Shepard, James F Amatruda, Howard M Stern, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapyAnnie Ogasawara, James R Kiefer, Herman Gill, et al.
Nature Communications|September 23, 2023
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancerLucia Taraborrelli, Yasin Şenbabaoğlu, Lifen Wang, et al.
Nature Immunology|March 22, 2022
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunityRosa Barreira da Silva, Ricardo M Leitao, Ximo Pechuan-Jorge, et al.
Nature Communications|August 5, 2023
Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumorsAlessandra Castiglioni, Yagai Yang, Katherine Williams, et al.
Pageof 4